Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 Trial of a Clostridium difficile Vaccine in Adults ≥50 Years
2016-003866-14Phase 3Completed
- Sponsor
- Pfizer
- Start
- Mar 2017
- Modality
- Vaccines & Immunotherapeutics, mRNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in Clostridioides difficile colitis (CDI) comparing Clostridium difficile vaccine 3-dose schedule with Placebo 3-dose schedule (2 arms). Started Mar 2017; status: completed.
02
Drugs
Clostridium difficile vaccine
03
Conditions
Clostridioides difficile colitis (CDI)
Beyond the preview
Go deeper on 2016-003866-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-003866-14.